Federal Supply Schedule 36F79725D0228
Award Date
9/1/25
Last Date to Order
8/31/30
Federal Agency
Veterans Integrated Service Network 12
Awardee
Autolus Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Autolus Inc., a foreign-owned for-profit organization, aims to procure drugs, pharmaceuticals, and hematology-related products. The contract has a ceiling value of $250,000.00 and a period of performance from March 4, 2025, to August 31, 2025. This is an interim agreement under FSS Schedule 65 I B, which covers the specified product categories. The...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Shorla Oncology Inc., a foreign-owned for-profit organization. The contract is for an interim agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products, with a ceiling value of $25,000.00 and a period of performance ending on August 14, 2024. The contract does not have any set-asides and is a multiple award, meaning...
The Federal Supply Schedule contract award is for Drugs, Pharmaceuticals, & Hematology Related Products (FSS Contract 65 I B) to Biofrontera Inc., a for-profit organization located in Woburn, MA. The contract has a period of performance from June 15, 2024 to June 15, 2029, with a ceiling value of $225,000.00. This multiple award contract was issued by the Veterans Integrated Service Network 12, a civilian agency. The contract aims to procure pharmaceuticals and related products for the...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...
The Federal Supply Schedule (FSS) contract award, with ID 36F79723D0229, was granted to Legacy Pharma USA, Inc., a foreign-owned, self-certified small disadvantaged business, for the provision of DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS. This multiple-award contract has a ceiling value of $6,150,000.00 and a period of performance ending on September 14, 2028. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department...
This Federal Supply Schedule contract was awarded to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business, by the Department of Veterans Affairs' Veterans Integrated Service Network 12. The contract has a ceiling value of $225,000.00 and a period of performance through May 14, 2030. The contract is for the procurement of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B schedule. While the specific products and services were not detailed...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12, a civilian federal agency, to GC Biopharma USA, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through January 14, 2025. The FSS contract is for the procurement of drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. Additionally, a Blanket Purchase Agreement (BPA) was awarded under this FSS contract with a ceiling value of...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued at up to $25,000.00, is an interim agreement under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Iovance Biotherapeutics Manufacturing LLC, a for-profit organization. The contract has a period of performance lasting until October 14, 2024. No...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Aurobindo Pharma USA Inc., a foreign-owned for-profit organization. The contract was awarded on March 15, 2020, with a ceiling value of $700,000.00 and a period of performance ending on March 14, 2026. The contract scope covers the procurement of drugs, pharmaceuticals, and hematology-related products under the General Services...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ars Pharmaceutical Operations, Inc. The $1,025,000.00 contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024 to March 14, 2025 and was set up as a multiple award vehicle with no set-asides. As an FSS contract, the awarded prime contractor...